Recombinant human IGF-1 alleviates dyslipidemia induced by lactational maternal dietary restriction

• by Xin Liu, Yuanyuan Ma, Hong Cui, Qi Feng

• June 4, 2026

The lipid–inflammation axis in rosacea: mechanistic insights and therapeutic implications

• by Xiaoyu Zhang, Tao Ning, Yanyan Feng

• May 4, 2026

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

• by Kathryn Wighton

• May 21, 2026

• 2 min

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

• by Kathryn Wighton

• May 29, 2026

• 3 min